Dry January Participation Linked to Noticeable Health Improvements

Translate to Spanish or other 102 languages!

In 2013, Alcohol Change UK started the “Dry January” campaign, where people could commit to abstaining from drinking alcohol for the entire month. Imgage for illustration purposes
In 2013, Alcohol Change UK started the “Dry January” campaign, where people could commit to abstaining from drinking alcohol for the entire month. Imgage for illustration purposes
- Advertisement -

Medical News Today

In 2013, Alcohol Change UK started the “Dry January” campaign, where people could commit to abstaining from drinking alcohol for the entire month. 

In January 2025, Alcohol Change UK reported that about 200,000 people globally signed up to participate in their Dry January challenge. 

- Advertisement -

Past studies show that taking part in Dry January may offer some positive health benefits. For example, research presented in January 2019 found that those who followed Dry January had higher energy levels and a healthier body weight

Follow the link below to read the full story:

https://www.medicalnewstoday.com/articles/dry-january-1-month-no-alcohol-difference-health-study?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2026-01-07&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -